Precept Management LLC Vericel Corp Transaction History

Precept Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$8.5 - $15.82 $850,850 - $1.58 Million	-100,100 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$7.25 - $19.22 $725,725 - $1.92 Million	100,100 New	100,100 $918,000
Q2 2019 Aug 14, 2019	SELL	$15.01 - $18.89 $546,364 - $687,596	-36,400 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$16.23 - $20.29 $545,328 - $681,744	-33,600 Reduced 48.0%	36,400 $637,000
Q4 2018 Feb 14, 2019	BUY	$10.77 - $18.44 $753,900 - $1.29 Million	70,000 New	70,000 $1.22 Million

277

48.8M

91.8K

23.2K

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.73B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

Get notified when there are updates to the investment portfolio of Precept Management LLC, based on Form 13F filings with the SEC.

Stay updated on Precept Management LLC with notifications on news.